GALMED PHARMACEUTICALS ($GLMD) posted quarterly earnings results on Thursday, May 22nd. The company reported earnings of -$0.62 per share, beating estimates of -$0.91 by $0.29. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $GLMD stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
